A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer
CONCLUSIONS: In this small pilot, PECs positively affected patients with prostate cancer, their clinicians, and the overall care system. Additional studies in larger populations and diverse settings will be useful.PMID:38387034 | DOI:10.1093/ajcp/aqae008 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 22, 2024 Category: Pathology Authors: Sarah E Bergholtz Sophia R Kurnot Esha Elahi Melissa DeJonckheere Sarah T Hawley Scott R Owens Simpa Salami Todd M Morgan Cathryn J Lapedis Source Type: research

Remote support of an external quality assessment program in 10 laboratories in Bhutan, Uganda, and Malawi: Pathologists Overseas experience between 2009 and 2017
CONCLUSIONS: External quality assessment programs can be successfully adopted long term by laboratories in low-resource settings. Active feedback requires significant time and effort but could be especially beneficial for laboratories with poor baseline performance.PMID:38387037 | DOI:10.1093/ajcp/aqae009 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 22, 2024 Category: Pathology Authors: Roa Harb Robert Tuggey Jack H Ladenson Timothy Amukele Source Type: research

Clinicopathologic features and survival outcomes of CD30 expression in extranodal natural killer/T-cell lymphoma
CONCLUSIONS: Positive CD30 expression was a favorable prognostic factor for ENKTL, and CD30 expression could restratify the survival of patients in clinical subgroups.PMID:38387041 | DOI:10.1093/ajcp/aqae012 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 22, 2024 Category: Pathology Authors: Ziyuan Shen Yubo Wang Ruiyang Xie Qing Zhang Xing Xing Shuo Zhang Hui Liu Wei Sang Source Type: research

MED15::TFE3 fusion renal cell carcinoma with extensive cystic change: A clinicopathologic and molecular genetic study of 2 cases, with an emphasis on differential diagnosis
CONCLUSIONS: The main differential diagnosis of MED15::TFE3 fusion RCC includes multilocular cystic renal neoplasm of low malignant potential and atypical renal cysts. Molecular confirmation of TFE3 fusion is essential for establishing the correct diagnosis.PMID:38387043 | DOI:10.1093/ajcp/aqae011 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 22, 2024 Category: Pathology Authors: Xiaona Yin Xingen Hu Jiayun Xu Danting Xiong Ming Zhao Source Type: research

A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer
CONCLUSIONS: In this small pilot, PECs positively affected patients with prostate cancer, their clinicians, and the overall care system. Additional studies in larger populations and diverse settings will be useful.PMID:38387034 | DOI:10.1093/ajcp/aqae008 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 22, 2024 Category: Pathology Authors: Sarah E Bergholtz Sophia R Kurnot Esha Elahi Melissa DeJonckheere Sarah T Hawley Scott R Owens Simpa Salami Todd M Morgan Cathryn J Lapedis Source Type: research

Remote support of an external quality assessment program in 10 laboratories in Bhutan, Uganda, and Malawi: Pathologists Overseas experience between 2009 and 2017
CONCLUSIONS: External quality assessment programs can be successfully adopted long term by laboratories in low-resource settings. Active feedback requires significant time and effort but could be especially beneficial for laboratories with poor baseline performance.PMID:38387037 | DOI:10.1093/ajcp/aqae009 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 22, 2024 Category: Pathology Authors: Roa Harb Robert Tuggey Jack H Ladenson Timothy Amukele Source Type: research

Clinicopathologic features and survival outcomes of CD30 expression in extranodal natural killer/T-cell lymphoma
CONCLUSIONS: Positive CD30 expression was a favorable prognostic factor for ENKTL, and CD30 expression could restratify the survival of patients in clinical subgroups.PMID:38387041 | DOI:10.1093/ajcp/aqae012 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 22, 2024 Category: Pathology Authors: Ziyuan Shen Yubo Wang Ruiyang Xie Qing Zhang Xing Xing Shuo Zhang Hui Liu Wei Sang Source Type: research

MED15::TFE3 fusion renal cell carcinoma with extensive cystic change: A clinicopathologic and molecular genetic study of 2 cases, with an emphasis on differential diagnosis
CONCLUSIONS: The main differential diagnosis of MED15::TFE3 fusion RCC includes multilocular cystic renal neoplasm of low malignant potential and atypical renal cysts. Molecular confirmation of TFE3 fusion is essential for establishing the correct diagnosis.PMID:38387043 | DOI:10.1093/ajcp/aqae011 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 22, 2024 Category: Pathology Authors: Xiaona Yin Xingen Hu Jiayun Xu Danting Xiong Ming Zhao Source Type: research

Artificial intelligence-based algorithms for the diagnosis of prostate cancer: A systematic review
CONCLUSIONS: The published evidence suggests that AI can be reliably used for prostate cancer detection and grading, assisting pathologists in the time-consuming screening of slides. Further technologic improvement would help widening AI's adoption in prostate pathology, as well as expanding its prognostic predictive potential.PMID:38381582 | DOI:10.1093/ajcp/aqad182 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 21, 2024 Category: Pathology Authors: Stefano Marletta Albino Eccher Filippo Maria Martelli Nicola Santonicco Ilaria Girolami Aldo Scarpa Fabio Pagni Vincenzo L'Imperio Liron Pantanowitz Stefano Gobbo Davide Seminati Angelo Paolo Dei Tos Anil Parwani Source Type: research

Immune checkpoint inhibitor-related colitis in patients on immunotherapy for cancer
CONCLUSIONS: Future successful management of this form of colitis relies on our comprehension of the intricate interplay between tumoral and systemic immune responses to immune checkpoint inhibitors and innovative approaches to modify these responses, along with specific immune cell populations, to preclude immune-related adverse events while achieving antitumor therapeutic outcomes.PMID:38377034 | DOI:10.1093/ajcp/aqae002 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 20, 2024 Category: Pathology Authors: Belinda L Sun Alexis S Elliott David Nolte Xiaoguang Sun Source Type: research

Immune checkpoint inhibitor-related colitis in patients on immunotherapy for cancer
CONCLUSIONS: Future successful management of this form of colitis relies on our comprehension of the intricate interplay between tumoral and systemic immune responses to immune checkpoint inhibitors and innovative approaches to modify these responses, along with specific immune cell populations, to preclude immune-related adverse events while achieving antitumor therapeutic outcomes.PMID:38377034 | DOI:10.1093/ajcp/aqae002 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 20, 2024 Category: Pathology Authors: Belinda L Sun Alexis S Elliott David Nolte Xiaoguang Sun Source Type: research

Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis
CONCLUSIONS: Flow cytometric immunophenotyping is a quick, sensitive, high-yield tool for evaluating the immunophenotype of mast cells. An abnormal FCI finding should prompt careful histologic evaluation and sensitive KIT D816V mutation testing to address the possibility of SM. CD2, CD25, and CD30 are important markers for the detection of immunophenotypic aberrancy of mast cells, and their frequencies of aberrancy differ across SM subtypes.PMID:38372648 | DOI:10.1093/ajcp/aqad187 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 19, 2024 Category: Pathology Authors: Okechukwu Valentine Nwogbo Hong Fang Wei Wang Jie Xu Roberto N Miranda Prithviraj Bose Chi Young Ok Jeffrey L Jorgensen L Jeffrey Medeiros Sa A Wang Source Type: research

To normalize or not?: Dilute Russell viper venom time testing
CONCLUSIONS: The lupus anticoagulant status by the dRVVT assay was not changed based on normalization. Normalization was of no clinical benefit in our patient population; therefore, there was no need for the extra calculation step. Normalization may be useful for intermethod and interlaboratory studies and not for within-method LA detection.PMID:38372653 | DOI:10.1093/ajcp/aqae004 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 19, 2024 Category: Pathology Authors: Yong Zhang Michael Creer Olajumoke O Oladipo Source Type: research

Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis
CONCLUSIONS: Flow cytometric immunophenotyping is a quick, sensitive, high-yield tool for evaluating the immunophenotype of mast cells. An abnormal FCI finding should prompt careful histologic evaluation and sensitive KIT D816V mutation testing to address the possibility of SM. CD2, CD25, and CD30 are important markers for the detection of immunophenotypic aberrancy of mast cells, and their frequencies of aberrancy differ across SM subtypes.PMID:38372648 | DOI:10.1093/ajcp/aqad187 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 19, 2024 Category: Pathology Authors: Okechukwu Valentine Nwogbo Hong Fang Wei Wang Jie Xu Roberto N Miranda Prithviraj Bose Chi Young Ok Jeffrey L Jorgensen L Jeffrey Medeiros Sa A Wang Source Type: research

To normalize or not?: Dilute Russell viper venom time testing
CONCLUSIONS: The lupus anticoagulant status by the dRVVT assay was not changed based on normalization. Normalization was of no clinical benefit in our patient population; therefore, there was no need for the extra calculation step. Normalization may be useful for intermethod and interlaboratory studies and not for within-method LA detection.PMID:38372653 | DOI:10.1093/ajcp/aqae004 (Source: American Journal of Clinical Pathology)
Source: American Journal of Clinical Pathology - February 19, 2024 Category: Pathology Authors: Yong Zhang Michael Creer Olajumoke O Oladipo Source Type: research